‘Historic’ $100 million Alzheimer’s bill passes in House, heads to president’s desk
By
Lois A. Bowers
Dec 20, 2018
A bipartisan bill that authorizes $100 million in funding over five years to create a new public health infrastructure to combat Alzheimer’s disease is headed to the president’s desk after being passed...
Women have higher tau, especially in setting of elevated Aβ
Apr 05, 2023
Later age at menopause and hormone therapy non-use also were associated with higher regional tau.
Exercise, chores, social visits linked to lower dementia risk
Jul 28, 2022
Comparable results were seen for dementia, vascular dementia, Alzheimer’s disease, and in analyses stratified by dementia polygenic risk score.
Lower Alzheimer’s risk seen with PDE5i initiation for erectile dysfunction
Feb 08, 2024
The greatest reduction in risk was seen for those receiving 21 to 50 phosphodiesterase type 5 inhibitor prescriptions.
Stress, depression linked to MCI, Alzheimer’s disease
Oct 20, 2023
Chronic stress and depression are independent risk factors and have an additive effect when combined.
$4 billion increase in Alzheimer’s funding needed to prevent ‘catastrophe,’ coalition with provider...
By
Kimberly Bonvissuto
Jul 11, 2023
Funding the national response to Alzheimer’s and related dementias is a “national priority, economic and budgetary necessity, health and moral imperative,” according to a coalition of 360 organizations...
Vicious cycle seen between daytime napping, Alzheimer’s dementia
Mar 25, 2022
Excessive daytime napping over a year predicts worse cognitive performance the following year, and vice versa.
More news for Friday, March 1
By
Kimberly Bonvissuto
Mar 01, 2024
What states spent on dementia care in 2010 through 2019 … Impaired sense of direction may be early sign of Alzheimer’s … Experiencing low healthcare quality is associated with greater dementia risk...
Instrumental activities of daily living test could ID Alzheimer’s disease
Jun 28, 2023
An association was found between simulated real-life IADL and interactions of amyloid and early tau accumulation in cognitively normal seniors.
Relapse risk for psychosis in dementia lower with continued pimavanserin
Jul 22, 2021
The findings were seen in a double-blind, randomized, placebo-controlled discontinuation trial that was stopped early for efficacy.